The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s enzyme replacement therapy market report forecasts the enzyme replacement therapy market size to grow to $14.79 billion by 2027, with a CAGR (compound annual growth rate) of more than 8%.

Learn More On The Enzyme Replacement Therapy Market Report 2023 – https://www.thebusinessresearchcompany.com/report/enzyme-replacement-therapy-global-market-report

Enzyme Replacement Therapy Market Size Forecast
The global enzyme replacement therapy market size is expected to grow from $10.03 billion in 2022 to $10.85 billion in 2023 at a compound annual growth rate (CAGR) of 8.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions and affecting many markets across the globe. The global enzyme replacement therapy market size is expected to reach $14.79 billion in 2027 at a CAGR of 8.1%.

North America held the largest enzyme replacement therapy market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Enzyme Replacement Therapy Market Driver ­– Rise In The Prevalence Of Rare, Chronic, And Inherited Disorders
For instance, in January 2023, according to a report issued by the US-based National Library of Medicine, which is operated by the federal government, the number of people in the USA aged 50 and older who have at least one chronic condition will increase by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. Therefore, the rising prevalence of rare, chronic, and inherited disorders will drive the growth of the enzyme replacement therapy market going forward.

Request for A Sample Of The Global Enzyme Replacement Therapy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10512&type=smp

Key Enzyme Replacement Therapy Market Trend – Product Approvals
Product approvals have emerged as the key trend gaining popularity in the enzyme replacement therapy market. Several enzyme replacement therapy medications introduced by large players are getting approvals in the market.

Enzyme Replacement Therapy Market Segment
1) By Enzyme Type: Agalsidase Alfa, Agalsidase Beta, Galsulfase, Other Enzyme Types
2) By Application: Gaucher Disease, Pompe Disease, Fabry Disease, Other Applications
3) By Route Of Administration: Oral, Parenteral
4) By End-Users: Hospitals, Infusion Centers, Other End-Users

Enzyme Replacement Therapy Market Major Players and Strategies
Major players in the enzyme replacement therapy market are Biomarin Pharmaceutical Inc., Leadiant Biosciences Inc., Pfizer Inc., Sanofi S.A., AbbVie Inc., Takeda Pharmaceutical Company Limited, Protalix BioTherapeutics Inc., Amicus Therapeutics Inc., Johnson & Johnson Services Inc., Digestive Care Inc., Nestle Health Science, Alexion Pharmaceuticals Inc., Allergan Plc., Actelion Pharmaceuticals Ltd., CANbridge Life Sciences Ltd., Chiesi Farmaceutici S.P.A., Astrazeneca Plc., Genzyme Corporation, and JCR Pharmaceutical Co. Ltd.

In November 2020, Retrophin Inc., a US-based biopharmaceutical company, acquired Orphan Technologies Ltd for an undisclosed amount. Through this acquisition, Retrophin Inc. will expand its pipeline of potential first-in-class therapies targeting rare diseases. Orphan Technologies Limited is a Switzerland-based biopharmaceutical company that operates in enzyme replacement therapy.

The Enzyme Replacement Therapy Global Market Report 2023 covers regional data on enzyme replacement therapy market size, enzyme replacement therapy market trends and drivers, opportunities, strategies, and enzyme replacement therapy market competitor analysis. The countries covered in the enzyme replacement therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Enzyme replacement therapy (ERT) refers to a sort of medical treatment in which patients with chronic disorders brought on by insufficient or failing enzymes are given alternative enzymes.

View More Reports Related To The Enzyme Replacement Therapy Market –
Enzyme Inhibitor Global Market Report 2023
Protein Hydrolysis Enzymes Global Market Report 2023
Specialty Enzymes Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: